Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
1,188.10
-52.50 (-4.23%)
Nov 4, 2026, 3:29 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 29,980 employees as of March 31, 2026. The number of employees increased by 2,063 or 7.39% compared to the previous year. That makes Zydus Lifesciences the 1,243rd largest employer in the world and 67th in India.
Employees
29,980
Change (1Y)
2,063
Growth (1Y)
7.39%
Revenue / Employee
10.12M INR
Profits / Employee
1.40M INR
Market Cap
1.19T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 29,980 | 2,063 | 7.39% |
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Dec 31, 2022 | 23,000 | -743 | -3.13% |
| Sep 30, 2022 | 23,000 | - | - |
| Jun 30, 2022 | 23,000 | -1,412 | -5.78% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 47,000 |
| Cipla | 31,369 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 16,946 |
| Divi's Laboratories | 11,565 |
Zydus Lifesciences News
- 7 hours ago - Zydus Lifesciences Q2 net profit drops 27% despite 29% revenue growth - The Times of India
- 11 hours ago - Zydus Lifesciences Transcript: Q2 26/27 - Transcripts
- 11 hours ago - Zydus Lifesciences Quarterly report: Q2 2027 - Filings
- 11 hours ago - Zydus Lifesciences Slides: Q2 2027 - Filings
- 22 days ago - USFDA accepts biosimilar application of Zydus and German firm for Keytruda - The Times of India
- 22 days ago - FDA Accepts BLA For Formycon And Zydus' Keytruda Biosimilar FYB206 ;Shares Rise - Nasdaq
- 6 weeks ago - Zydus Lifesciences proposes ₹1,000cr university near Ahmedabad - The Times of India
- 2 months ago - Mereo BioPharma Licenses Alvelestat Rights To Sentynl Therapeutics - Nasdaq